Search

Your search keyword '"Pavlakis, Nick"' showing total 1,013 results

Search Constraints

Start Over You searched for: Author "Pavlakis, Nick" Remove constraint Author: "Pavlakis, Nick"
1,013 results on '"Pavlakis, Nick"'

Search Results

1. A Phase II trial of alternating osimertinib and gefitinib therapy in advanced EGFR-T790M positive non-small cell lung cancer: OSCILLATE

6. INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG)

8. ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance

9. Dual [68Ga]DOTATATE and [18F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score

10. A tailored approach to horizon scanning for cancer medicines

11. Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

13. Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis

15. Asian Thoracic Oncology Research Group (ATORG) Expert Consensus Statement on MET Alterations in NSCLC: Diagnostic and Therapeutic Considerations

20. Metabolic Tumor Volume on 18-Fluorodeoxyglucose Positron Emission Tomography as a Prognostic Marker of Survival in Patients With Locally Advanced or Metastatic Neuroendocrine Neoplasms Treated With 177Lutetium-DOTA-Octreotate Peptide Receptor Radionuclide Therapy.

21. Therapeutic drug monitoring of osimertinib in EGFR mutant non‐small cell lung cancer by dried blood spot and plasma collection: A pilot study.

22. CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non–Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy.

23. National screening for colorectal cancer is associated with stage shift to earlier diagnosis.

24. Lurbinectedin in small cell lung cancer: real‐world experience of a multicentre national early access programme.

26. Accreditation Standard Guideline Initiative for Tai Chi and Qigong Instructors and Training Institutions.

27. First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study

30. Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions

31. Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer

33. Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in

36. [18F]FDG PET/CT–Avid Discordant Volume as a Biomarker in Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Study

38. Accuracy of oncologists’ estimates of expected survival time in advanced cancer

39. MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG)

42. Whole genomes redefine the mutational landscape of pancreatic cancer

43. Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial

44. Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non–Small Cell Lung Cancer in the Global Phase III ALEX Study

46. ASPiRATION: Australian observational cohort study of comprehensive genomic profiling in metastatic lung cancer tissue.

47. NABNEC: A randomised phase II study of nab -paclitaxel in combination with carboplatin as first line treatment of gastrointestinal neuroendocrine carcinomas (GI-NECs).

48. ASPiRATION: Australian observational cohort study of comprehensive genomic profiling in metastatic lung cancer tissue

Catalog

Books, media, physical & digital resources